Home » Stocks » Avinger

Avinger, Inc. (AVGR)

Stock Price: $0.266 USD -0.014 (-5.00%)
Updated Oct 27, 2020 4:00 PM EDT - Market closed
After-hours: $0.270 +0.004 (1.47%) Oct 27, 7:53 PM

Stock Price Chart

Key Info

Market Cap 22.59M
Revenue (ttm) 8.70M
Net Income (ttm) -19.60M
Shares Out 84.92M
EPS (ttm) -1.55
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 27, 2020
Last Price $0.266
Previous Close $0.280
Change ($) -0.014
Change (%) -5.00%
Day's Open 0.280
Day's Range 0.262 - 0.282
Day's Volume 3,119,163
52-Week Range 0.241 - 1.630

More Stats

Market Cap 22.59M
Enterprise Value 18.15M
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 84.92M
Float 84.58M
EPS (basic) -1.78
EPS (diluted) -1.55
FCF / Share -0.59
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 539,509
Short Ratio 0.14
Short % of Float 0.64%
Beta 1.68
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 2.60
PB Ratio 3.35
Revenue 8.70M
Operating Income -18.70M
Net Income -19.60M
Free Cash Flow -16.04M
Net Cash 4.44M
Net Cash / Share 0.05
Gross Margin 32.96%
Operating Margin -214.93%
Profit Margin -268.10%
FCF Margin -184.43%
ROA -40.50%
ROE -224.34%
ROIC -223.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (2)

Buy 1
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

Current: $0.266
Target: 1.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth15.36%-20.32%-48.3%79.35%-4.46%-13.51%51.45%-
Gross Profit2.871.38-3.074.774.244.704.764.41
Operating Income-19.36-23.03-42.55-50.72-40.69-25.03-36.97-33.86
Net Income-19.45-27.56-48.73-56.13-47.34-31.96-39.90-33.86
Shares Outstanding7.
Earnings Per Share-3.18-33.42-749.72-1,355.70-1,751.00-53,273.30-68,208.00-64,812.00
Operating Cash Flow-17.26-18.47-34.48-53.07-40.88-21.80-40.66-35.23
Capital Expenditures-0.07--0.04-0.97-0.58-0.12-0.50-0.29
Free Cash Flow-17.33-18.47-34.52-54.04-41.46-21.92-41.15-35.52
Cash & Equivalents10.9416.415.3936.1043.0612.3212.2220.62
Total Debt8.977.4944.7441.2929.5728.7133.78-
Net Cash / Debt1.988.92-39.36-5.1913.49-16.39-21.5620.62
Book Value6.909.46-35.694.2415.59-144-113-73.64
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Avinger, Inc.
Country United States
Employees 74
CEO Jeffrey M. Soinski

Stock Information

Ticker Symbol AVGR
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: AVGR
IPO Date January 30, 2015


Avinger, a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.